Xie Ju Hua - Net Worth and Insider Trading
Xie Ju Hua Net Worth
The estimated net worth of Xie Ju Hua is at least $5.3 Billion dollars as of 2024-06-24. Xie Ju Hua is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd and owns about 439,682,951 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) stock worth over $5.3 Billion. Details can be seen in Xie Ju Hua's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Xie Ju Hua has not made any transactions after 2022-07-11 and currently still holds the listed stock(s).
Transaction Summary of Xie Ju Hua
Xie Ju Hua Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Xie Ju Hua owns 1 companies in total, including Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) .
Click here to see the complete history of Xie Ju Hua’s form 4 insider trades.
Insider Ownership Summary of Xie Ju Hua
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | Director |
Xie Ju Hua Latest Holdings Summary
Xie Ju Hua currently owns a total of 1 stock. Xie Ju Hua owns 439,682,951 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) as of July 11, 2022, with a value of $5.3 Billion.
Latest Holdings of Xie Ju Hua
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:603707 | Nanjing King-Friend Biochemical Pharmaceutical Co Ltd | 2022-07-11 | 439,682,951 | 11.96 | 5,258,608,094 |
Holding Weightings of Xie Ju Hua
Xie Ju Hua Form 4 Trading Tracker
According to the SEC Form 4 filings, Xie Ju Hua has made a total of 16 transactions in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is the sale of 101,465,296 shares on July 11, 2022, which brought Xie Ju Hua around $0.
Insider Trading History of Xie Ju Hua
- 1
Xie Ju Hua Trading Performance
GuruFocus tracks the stock performance after each of Xie Ju Hua's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Xie Ju Hua is -9.52%. GuruFocus also compares Xie Ju Hua's trading performance to market benchmark return within the same time period. The performance of stocks bought by Xie Ju Hua within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Xie Ju Hua's insider trading performs compared to the benchmark.
Performance of Xie Ju Hua
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.27 | | | | | |
| Relative Return to S&P 500(%) | -8.25 | | | | | |
Xie Ju Hua Ownership Network
Xie Ju Hua Owned Company Details
What does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd do?
Who are the key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd?
Xie Ju Hua is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. Other key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd include Supervisors Liu Zu Qing , senior management Wu Gui Ping , and senior management Qian Xiao Jie .
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions
Xie Ju Hua Mailing Address
Above is the net worth, insider trading, and ownership report for Xie Ju Hua. Currently GuruFocus does not have mailing address information for Xie Ju Hua.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
